Faculty profile

Eric Cohen

ResearcherUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses and email address may be missing. Find their university profile.

Eric Cohen

Researcher

Health Sciences

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
1 publication in the last five years, latest in 2025.
Principal investigator on 12 research grants (12 CIHR), most recently in 2024.
Supervised 3 trainees who won CIHR awards, most recently in 2019.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Hiv/Aids Hiv Persistence Humanized Mouse Models Hiv Cure Human Studies Myeloid Cells Therapeutic Interventions Hiv Latency

Latest papers

The CanCURE Survey: Gender-Based Differences in HIV Cure Research Priorities.
Journal of personalized medicine · 2025
Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound.
The American journal of cardiology · 2006

All 2 publications

Latest funding

Identification of Aryl Hydrocarbon Receptor as a Novel Druggable Modulator of HIV-1 Latency
CIHR · 2024 · Co-investigator
$1,285,200
Canadian HIV Cure Enterprise 3.0: Targeting tissue HIV reservoirs
CIHR · 2024 · Principal investigator
$3,750,000
Identification of Aryl Hydrocarbon Receptor as a Novel Druggable Modulator of HIV-1 Latency
CIHR · 2023 · Co-investigator
$100,000

All 21 grants and awards

Identification of Aryl Hydrocarbon Receptor as a Novel Druggable Modulator of HIV-1 Latency

Co-investigatorCIHR2024Project Grant

Principal investigators: Ancuta, Petronela

Keywords: Antiretroviral Therapy; Aryl Hydrocarbon Receptor (Ahr); Confocal Microscopy/Imagestream; Crispr Cas9, Sirna; Flow Cytometry Analysis And Sorting; Hiv-1 Viral Reservoirs; Humanized Mice For Hiv Infection; Latency Reversing Agents; Pcr/Rt-Pcr, Western Blotting; Rna Sequencing, Massspec, Chip-Seq, Cut&Run, Atac-Seq

$1,285,200

Canadian HIV Cure Enterprise 3.0: Targeting tissue HIV reservoirs

Principal investigatorCIHR2024TG: Biomedical Res. for HIV/AIDS/STBBI-Next-Gen.Therapeutic Interv.-Large Team

Principal investigators: Chomont, Nicolas; Margolese, Shari L; Ancuta, Petronela; Angel, Jonathan B; Cohen, Eric A; Costiniuk, Cecilia T; Murooka, Thomas T

Keywords: Cd4 T Cells; Hiv Cure; Hiv Immunity; Hiv Persistence; Hiv Reservoir; Human Studies; Humanized Mouse Models; Myeloid Cells; Therapeutic Interventions; Tissue

$3,750,000

Identification of Aryl Hydrocarbon Receptor as a Novel Druggable Modulator of HIV-1 Latency

Co-investigatorCIHR2023Project Grant - Priority Announcement: Infection and Immunity

Principal investigators: Ancuta, Petronela

Keywords: Antiretroviral Therapy; Confocal Microscopy/Imagestream; Crispr Cas9; Flow Cytometry Analysis And Sorting; Hiv-1; Humanized Mice For Hiv Infection; Latency Reversing Agents; Pcr/Rt-Pcr; Rna Sequencing; Viral Reservoirs

$100,000

The Th17 Master Regulator RORC2 as a New Target for HIV Immune Therapy and Cure Strategy

Co-investigatorCIHR2021Project Grant

Principal investigators: Ancuta, Petronela

Keywords: Antiretroviral Therapy; Chromatin Ip; Confocal Microscopy/Image Stream; Crispr Cas9; Flow Cytometry Sorting; Hiv-1; Humanized Mice; Rna Sequencing; Rorc2; Th17 Cells

$887,400

The Th17 Master Regulator RORC2 as a New Target for HIV Immune Therapy and Cure Strategy

Co-investigatorCIHR2020Project Grant - Priority Announcement: HIV/AIDS and STBBI

Principal investigators: Ancuta, Petronela

Keywords: Confocal Microscopy; Crispr Cas9; Hiv Transcription; Hiv-1; Human Th17 Cells; Humanized Mice; Image Stream; Rna Sequencing; Rorc2 Reverse Agonists; Viral Reservoir Reactivation And Purging

$100,000

Second mitochondrial activator of caspases (SMAC) Mimetics as novel HIV Latency Reversal Agents for HIV eradication

SupervisorCIHR2019Fellowship - Priority Announcement - HIV/AIDS and/or STBBI

Principal investigators: Jain, Jaspreet

Keywords: Caspase; Cd4+ T Cells; Hiv; Humanised Blt Mice; Inhibitor Of Apoptosis Proteins (Iaps); Latency; Non-Cannonical Nf-Kb Pathway; Smac Mimetics

$135,000

Canadian HIV Cure Enterprise 2.0: Targeting the interplay between myeloid cells and CD4+ T-cells for HIV cure

Nominated PICIHR2018Team Grant: HIV/AIDS Biomedical and Clinical Research - Cure - Large

Principal investigators: Cohen, Eric A; Margolese, Shari L; Rosenes, Ron; Ancuta, Petronela; Angel, Jonathan B; Chomont, Nicolas; Estaquier, Jérôme; Murooka, Thomas T; Routy, Jean-Pierre

Keywords: Hiv Cure; Hiv Latency; Hiv Persistence; Hiv Reservoirs; Human Studies; Humanized Mouse Models; Memory Cd4+ T-Cells; Myeloid Cells; Non-Human Primate Model; Therapeutic Interventions

$6,000,000

Plasmacytoid dendritic cells in HIV infection

Nominated PICIHR2016Project Grant

Principal investigators: Cohen, Eric A; Haddad, Elie

Keywords: Biology Of Early Hiv Infection; Dendritic Cells; Flow Cytometry; Flt3 Ligand; Hiv Immunopathogenesis; Hiv Replication And Spread; Hiv/Aids; Humanized Mouse Models; Innate Immunity; Protective Anti-Hiv Immune Responses

$100,000

Targeting of host antiviral and immune-modulatory factors by HIV-1 Vpu: Implications for viral pathogenesis and therapy

Nominated PICIHR2016Project Grant

Principal investigators: Cohen, Eric A

Keywords: Anti-Hiv Immune Responses; Bst2/Tetherin; Cell Biology; Hiv-1 Immune Evasion; Hiv-1 Pathogenesis; Hiv-1 Persistence; Hiv-1 Therapy; Hiv-1 Vpu; Host Immuno-Modulatory Factors; Molecular Virology

$710,985

Examining the role of plasmacytoid dendritic cells in the control of HIV infection using humanized mice

Nominated PICIHR2016Operating Grant: Innovative Biomedical and Clinical HIV/AIDS Research

Principal investigators: Cohen, Eric A; Haddad, Elie

Keywords: Biology Of Early Hiv Infection; Dendritic Cells; Flow Cytometry; Flt3 Ligand; Hiv Replication And Spread; Hiv-1 Pathogenesis; Hiv/Aids; Humanized Mouse Models; Innate Immunity; Protective Immune Reponses

$248,700

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Eric Cohen

Research

Latest papers

Latest funding

The CanCURE Survey: Gender-Based Differences in HIV Cure Research Priorities.

Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound.

Identification of Aryl Hydrocarbon Receptor as a Novel Druggable Modulator of HIV-1 Latency

Canadian HIV Cure Enterprise 3.0: Targeting tissue HIV reservoirs

Identification of Aryl Hydrocarbon Receptor as a Novel Druggable Modulator of HIV-1 Latency

The Th17 Master Regulator RORC2 as a New Target for HIV Immune Therapy and Cure Strategy

The Th17 Master Regulator RORC2 as a New Target for HIV Immune Therapy and Cure Strategy

Second mitochondrial activator of caspases (SMAC) Mimetics as novel HIV Latency Reversal Agents for HIV eradication

Canadian HIV Cure Enterprise 2.0: Targeting the interplay between myeloid cells and CD4+ T-cells for HIV cure

Plasmacytoid dendritic cells in HIV infection

Targeting of host antiviral and immune-modulatory factors by HIV-1 Vpu: Implications for viral pathogenesis and therapy

Examining the role of plasmacytoid dendritic cells in the control of HIV infection using humanized mice

Frequent collaborators

Renee Masching

Wangari Tharao

Nicolas Chomont

Nicolas Chomont

Renee Masching

Renee Masching

Wangari Tharao